Prestige Must Shed Bonine To Win FTC Nod On $750M Deal
The Federal Trade Commission will require pharmaceutical company Prestige Brands Holdings Inc. to divest assets connected with the motion sickness drug Bonine to resolve competition concerns over its proposed $750 million...To view the full article, register now.
Already a subscriber? Click here to view full article